PuSH - Publikationsserver des Helmholtz Zentrums München

Malinowsky, K.* ; Wolff, C.* ; Berg, D.* ; Schuster, T.* ; Walch, A.K. ; Bronger, H.* ; Mannsperger, H.* ; Schmidt, C.* ; Korf, U.* ; Höfler, H.* ; Becker, K.F.*

uPA and PAI-1-related signaling pathways differ between primary breast cancers and lymph node metastases.

Transl. Oncol. 5, 98-104 (2012)
Verlagsversion Volltext DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The supporting role of urokinase-type plasminogen activator (uPA) and its inhibitor plasminogen activator inhibitor 1 (PAI-1) in migration and invasion is well known. In addition, both factors are key components in cancer cell-related signaling. However, little information is available for uPA and PAI-1-associated signaling pathways in primary cancers and corresponding lymph node metastases. The aim of this study was to compare the expression of uPA and PAI-1-associated signaling proteins in 52 primary breast cancers and corresponding metastases. Proteins were extracted from formalin-fixed paraffin-embedded tissue samples of the primary tumors and metastases. Protein lysates were subsequently analyzed by reverse phase protein array for the expression of members of the PI3K/AKT (FAK, GSK3-β, ILK, pGSK3-β, PI3K, and ROCK) and the MAPK pathways (pp38, pSTAT3, and p38). A solid correlation of uPA expression existed between primary tumors and metastases, whereas PAI-1 expression did not significantly correlate between them. The correlations of uPA and PAI-1 with signaling pathways found in primary tumors did not persist in metastases. Analysis of single molecules revealed that some correlated well between tumors and metastases (FAK, pGSK3-β, ILK, Met, PI3K, ROCK, uPA, p38, and pp38), whereas others did not (PAI-1 and GSK3-β). Whether the expression of a protein correlated between tumor and metastasis or not was independent of the pathway the protein is related to. These findings hint at a complete deregulation of uPA and PAI-1-related signaling in metastases, which might be the reason why uPA and PAI-1 reached clinical relevance only for lymph node-negative breast cancer tissues.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.393
0.000
28
27
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter PLASMINOGEN-ACTIVATOR INHIBITOR-1; PHASE PROTEIN ARRAYS; UROKINASE-TYPE; P38 MAPK; MICROARRAY ANALYSIS; ENDOTHELIAL-CELLS; E-CADHERIN; C-JUN; EXPRESSION; KINASE
Sprache englisch
Veröffentlichungsjahr 2012
HGF-Berichtsjahr 2012
e-ISSN 1936-5233
Quellenangaben Band: 5, Heft: 2, Seiten: 98-104 Artikelnummer: , Supplement: ,
Verlag Neoplasia Press
Begutachtungsstatus Peer reviewed
POF Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-500300-001
G-500390-001
PubMed ID 22496926
Scopus ID 84859475199
Erfassungsdatum 2012-12-03